心肌疾病中的心上脂肪组织:从生理学到心力衰竭表型
Alexios S Antonopoulos1, Charalampos Papastamos2, Dennis V Cokkinos3
11st Cardiology Department, National and Kapodistrian University of Athens, Athens, Greece; Clinical, Experimental Surgery and Translational Research Centre, Biomedical Research Foundation Academy of Athens, Athens, Greece.
Current problems in cardiology
|May 27, 2023
概括
副心脏脂肪组织 (EAT) 通过影响心脏功能和新陈代谢,影响心脏健康. 了解这种EAT-心脏联系为心力衰竭 (HF) 提供了新的诊断和治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 脂肪组织研究研究
- 心脏的新陈代谢.
背景情况:
- 脊心脂肪组织 (EAT) 是一个活跃的内分泌器官,影响心肌生物学.
- 功能障碍的饮食,通常与肥胖有关,会对心脏代谢,炎症和纤维化产生不利影响.
- 人们越来越多地认识到EAT和心力衰竭 (HF) 之间的双向关系.
研究的目的:
- 总结一下心上脂肪组织与心脏之间的复杂联系.
- 探索研究心表脂肪如何增强对心脏疾病的理解.
- 突出EAT作为诊断/预后生物标志物和高频治疗标的潜力.
主要方法:
- 关于心表脂肪组织和心脏功能的当前科学文献的综述.
- 分析EAT在心脏能量,收缩性,透缩功能和心房导电中的作用.
- 讨论非侵入性成像和人工智能增强的工具,以检测高频的EAT变化.
主要成果:
- 由肥胖驱动的饮食功能障碍导致心肌细胞炎症,氧化还原失衡和纤维化.
- EAT通过代谢和炎症信号显著影响心脏表型.
- 在心力衰竭中可以观察到EAT的改变,并且可以使用先进的成像技术检测到.
结论:
- 心脂肪组织在确定心脏健康和疾病方面发挥着至关重要的作用.
- EAT是心血管疾病中新型诊断和预后生物标志物的潜在来源.
- 准EAT是一个有希望的治疗途径,可以改善心力衰竭的临床结果.
相关概念视频
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy I: Introduction and Classification
24
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
24
Heart Failure I: Introduction
24
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
24
Heart Failure IV: Classification and Diagnostic Evaluation
21
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
21


